ASX Announcement FY26 RESULTS RELEASE AND INVESTOR CALL 21 August 2026, Adelaide, Australia: Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), announces that it will release its financial statements for the full year ended 30 June 2026 (FY26) on...
Notification of date for release of FY26 results
Filed with ASX · · 1 page · English
Summary by 6ix AI
The company's CEO and CFO will host a webcast to discuss the results on the same day as the release. Participants can register for the webcast through a provided link.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Upcoming presentation of Imvexxy clinical data
- Mayne Pharma launches Investor Hub
- Initial Director's Interest Notice
- Mayne Pharma Bioshares Summit Presentation
- Notification of cessation of securities - MYX
Later from Mayne Pharma
- 2026 Corporate Governance Statement and Appendix 4G
- 2026 Full Year Results Investor Presentation
- 2026 Appendix 4E and Annual Report
- 2026 Full Year Results Media Release
- Application for quotation of securities - MYX
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma